comprehensive -WSS

comprehensive

author：entertainment 2025-08-12 11:29:43 - browse：27

Boston Globe

A commonly prescribed medication for children’s asthma is disappearing from pharmacists’ shelves, forcing parents and pediatricians to scramble for alternatives just as allergy season is about to start.

In a move unusual for such a widely used drug, GlaxoSmithKline discontinued Flovent HFA, the brand name of its corticosteroid treatment fluticasone propionate, at the end of December. Critics, including Massachusetts Senator Elizabeth Warren, say the decision helps the company avoid new Medicaid penalties going into effect this year for medications with price increases that outpace inflation.

“It was all very confusing, and we were left scrambling, trying to find out what we could do,” said Simone Fung, whose 5-year-old son, David, endured worse asthma symptoms over the past two months as the Cambridge family navigated confusing insurance policies and shortages of alternative medications to find a replacement for Flovent.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Ukraine and a new approach to mental health in war

WSS

Biotech lab space demand falls sharply

Problems with a popular proposal to regulate AI in health care

Emergency workers more likely to restrain Black patients: study

Why are Kaiser Permanente staff considering a strike?

Global cancer cases to surge 77% by 2050, WHO report says

Senate HELP committee spars over health care workforce policies

knowledge

comprehensive

Wikipedia

Medicare details structure of new drug price negotiation program

Texas Medical Board asked to define abortion emergency exception

Cancer drug shortages should be causing more outrage

AstraZeneca stays mum on Medicare drug pricing negotiations

In Memoriam: Notable people who died in 2023

Lasker Awards 2023: Winners in biomedical research

George Santos makes 1st court appearance after pleading not guilty to 13 counts

340B reform proposal comes out of Senate working group

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Devoted Health’s losses in Medicare Advantage persist

leisure time

The Biogen Aduhelm mess could happen again

Devoted Health’s losses in Medicare Advantage persist

Readout Newsletter: Amgen, Regeneron, BGI Group and more

How AI helped researchers track recovery from depression

Johnson & Johnson sued for allegedly overpaying for workers' drugs

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

leisure time

hotspot

Wikipedia

hotspot